Categories
Technology

Toyota’s Camry, best-selling car in US, goes all-hybrid

By Joseph White

DETROIT (Reuters) – The next generation of the Toyota Camry, the best-selling sedan in the U.S. market, will come with only a gas-electric hybrid powertrain, the boldest move yet by the Japanese automaker to push hybrid technology into the heart of the U.S. market.

The 2025 Camry will combine a 2.5-liter gasoline engine with an electric drive system tuned to deliver more power in both front-wheel drive and all-wheel drive versions of the car, Toyota said.

Compliance with tougher U.S. fuel economy rules was a factor in Toyota’s decision to make the new Camry an all-hybrid vehicle line, dropping four- and six-cylinder combustion models that made up about 85% of sales in the current model year, David Christ, head of the Toyota brand in North America, told Reuters. Another factor behind the decision was “the performance we were able to get out of the hybrid,” he said.

While Toyota has accelerated development of electric-vehicle technology, it is still betting that demand for hybrids and plug-in hybrids will remain robust as the automaker takes a “multi-pathway” approach seeking to satisfy customer needs in every market.

The hybrid powertrain and a new electronic all-wheel drive system deliver 232 combined horsepower – nearly 15% more than the outgoing Camry with a mechanical all-wheel drive system, Toyota said.

Toyota executives unveiled the ninth generation of the midsized Camry sedan on Tuesday in Los Angeles, ahead of the Los Angeles Auto Show that opens on Friday.

The new Camry will compete in a segment largely abandoned by the Detroit brands, with the exception of General Motors’ Chevrolet Malibu. The new Camry’s direct competitors – putting aside scores of compact and midsized SUVs – will include a few remaining sedans such as the Honda Accord, the Hyundai Sonata and Tesla’s all-electric Model 3.

The Tesla Model 3 outsold the Camry in California, a key market for Toyota, during the first nine months of 2023, according to data from the California New Car Dealers Association.

Toyota did not disclose pricing or fuel-efficiency figures for the 2025 Camry, due in showrooms next spring. The cheapest Camry hybrid model currently sells for about $2,400 more than the most inexpensive combustion Camry.

Most of the hybrid powertrains sell at a $1,500 to $2,000 premium to combustion models, Christ said. “We think the value the hybrid powertrain brings is worth that kind of premium.”

A current Camry hybrid is rated at 52 miles (84 km) per gallon in combined city and highway driving, compared with a 32-mpg rating for the conventional four-cylinder Camry. The hybrid saves $650 a year in fuel costs compared with the combustion model, according to U.S. government fuel economy data.

Toyota previously switched its Sienna minivan to an all-hybrid powertrain approach. The Sienna is “our second-fastest turning car and the car we have the most reservations for,” Christ said.

(Reporting by Joe White in Detroit; Editing by Matthew Lewis)`

Categories
Business Technology

Rivian signs agreements with Georgia to start building EV factory (Nov 13)

(Reuters) – (This Nov. 13 story has been corrected throughout to remove the reference to Rivian’s plans to raise nearly $15 bln in debt for an EV plant in Georgia and instead to say that the company has signed an agreement with the state that will allow it to start building a planned EV factory)

Rivian Automotive said in a filing on Monday it signed agreements with the state of Georgia that will allow it to start building a planned electric-vehicle factory.

The agreement provides for Rivian to rent land, and machinery to operate the plant, for which the company will pay about $300 million in property tax payments.

Rivian first announced its $5 billion EV factory just outside of Atlanta, Georgia in late 2021. Those lease payments to Georgia could increase if the investment Rivian committed to increases beyond $5 billion. The agreement is set to expire Dec. 1, 2047.

The new plant will employ more than 7,500 people and eventually build 400,000 vehicles a year.

(Reporting by Anirudh Saligrama in Bengaluru; Editing by Rashmi Aich)

tagreuters.com2023binary_LYNXMPEJAD016-VIEWIMAGE

Categories
Crypto

Cryptoverse: Bitcoin miners make money ahead of ‘halving’

By Medha Singh and Lisa Pauline Mattackal

(Reuters) – Bitcoin miners are making hay while the sun shines.

The business has been yanked out of the doldrums by the cryptocurrency’s recent rally – and now mining companies are racing to lock in profits before bitcoin’s “halving”, when rewards for producing the tokens are cut in half.

The next halving is expected in April 2024, a process designed to slow the release of bitcoin, whose supply is capped at 21 million – of which 19 million have already been mined.

“You’re seeing a lot of urgency to plug rigs in ahead of the halving,” said Gregory Lewis, analyst at brokerage BTIG that covers the 13 biggest U.S.-listed bitcoin miners.

Bitcoin’s hashrate – a measure of the computational power needed to mine a coin – has spiked to an all-time high, according to crypto platform Blockchain.com. That means miners are having to use more and more power and speed to crack the complex maths puzzles that earn them a bitcoin.

Analysts at J.P. Morgan estimate the hashrate has hit record highs for 11 consecutive months, including a historic surge in October.

PLAYING THE GAME

Bitcoin has risen about 37% in the past month to around $37,000 after months of listlessness, a rebound that’s encouraged miners to hook up their powerful computers to crack the puzzles and sell newly minted coins.

The 30-day average of revenue earned by miners has improved steadily this year to hit a 18-month at $32.46 million on Nov. 11, blockchain.com data shows.

However, mining – a highly energy-intensive process – is still not as profitable as in its 2021 heyday.

A measure of miners’ earnings from using 1 petahash per second of computing power in a day has risen to over $81 from $70 at the start of November but remains well below a peak of $127 in early May, according to mining data platform Hashrate Index.

With six months to go till miners’ share of rewards is slashed, they are looking for ways to keep their margins from shrinking in the highly competitive environment.

“Every halving forces miners not playing that game at a high enough level to get washed out,” said William Szamosszegi, CEO of mining company Sazmining.

HALVING OPPORTUNITY

Bitcoin prices have typically rallied in the past following halvings. Six months after the first halving in 2012, the price jumped to $126 from $12. After the second halving in 2016, it went to $1,000 from $654 within seven months and in 2020 it shot up to $18,040 from $8,570 in the same time period.

Bitcoin’s third halving in 2020 brought down miner rewards to 6.25 bitcoin per block and the upcoming one is set to push it down to 3.125 in April.

At current prices, mining each block reaps $231,250.

Matteo Greco, analyst at digital asset investment company Fineqia International, said many mining companies were upgrading their equipment and boosting their hashrate power to stay competitive.

To conserve their profit margins, some players have resorted to moving their operations to Central American countries where energy prices are more affordable, and governments friendlier to cryptocurrencies.

“It’s too early to say if all bitcoin miners are out of the wood,” said Ludovic Thomas, portfolio manager at Swiss-based Criptonite Asset Management that invests in digital assets. “Profitability increase always leads to network hashrate and difficulty increase.”

(Reporting by Medha Singh and Lisa Mattackal in Bengaluru; Editing by Vidya Ranganathan and Pravin Char)

Categories
Pharma Stocks

Wegovy’s heart benefits due to more than weight loss, Novo says

By Patrick Wingrove

PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone, according to new data presented at a major medical meeting on Saturday.

Early data from the Danish drugmaker’s Select trial released in August demonstrated that Wegovy, which has been shown to help patients lose an average of 15% of their weight, also reduced incidence of heart attack, stroke or death from heart disease by 20%.

Full results from the study, presented at the American Heart Association annual scientific meeting in Philadelphia in front of a standing room only crowd and published in the New England Journal of Medicine, suggest the drug has other beneficial effects beyond the known health benefits from losing weight.

The heart risk difference between patients who received Wegovy, known chemically as semaglutide, and those on placebo began to appear almost immediately after starting treatment, researchers said.

In the study of overweight and obese patients based on body mass index who had preexisting heart disease but not diabetes, Wegovy reduced the risk of non-fatal heart attack by 28%, non-fatal stroke by 7% and heart-related death by 15% compared to a placebo.

Given that patients had not started losing weight when the cardiovascular benefits first appeared suggests the heart protection was not purely the result of weight loss, Novo said.

Dr Chad Weldy, a cardiologist at Stanford University, said on the sidelines of the conference that it was important to note that the trial did not study how semaglutide might stop heart disease from happening and only looked at how to stop it from getting worse.

Despite that, the size of the patient population covered by this trial should make doctors think about the sorts of patients who should be prescribed Wegovy based on the data.

“Anyone who has had a heart attack or obstructive coronary disease and has a body mass index of more than 27 fits in with this study, which is a very large patient population,” he said.

Dr Bruno Halpern, head of the obesity center at Hospital 9 de Julho in São Paulo, Brazil, also said at the conference that Wegovy should now be a frontline treatment for heart disease.

The study researchers said that while understanding of the mechanisms of the cardiovascular protection from semaglutide remain speculative, there was a consistent effect on associated risk factors that support the idea that multiple pathways are behind the drug’s clinical benefit.

The associated risk factors include inflammation, blood pressure and blood sugar control, all of which can impact heart health.

John Deanfield, one of the study’s authors and cardiology professor at University College London, said at the medical meeting that the trial data would spur a debate over where Wegovy fits into doctors’ treatments.

“When do we start these drugs in our patients? How do we stop them? How much weight do we want them to lose to get the benefit?” he said.

Patients on Wegovy experienced decreases in C-reactive proteins, an indication of inflammation, similar to those reported with cholesterol lowering statins, which are known to significantly lower heart risks, researchers reported.

“The cardiovascular benefit (of Wegovy) is a combination of many factors, but I would call out glycemic (blood sugar) control, weight loss and inflammation,” Martin Lange, Novo Nordisk’s head of development, said in an interview.

In the 17,604-patient trial with a mean duration of 33 months, almost 1,500 of those taking Wegovy discontinued treatment due to adverse side effects, mostly gastrointestinal disorders like nausea and vomiting, compared to 718 patients in the placebo group, according to the study.

Though the trial was not conducted to test weight loss, participants lost an average of nearly 10% of their total body weight. Novo said patients in the heart study were not required to track diet and exercise as they are in obesity trials.

The study showed Wegovy to be safe and well-tolerated in line with previous semaglutide trials, Novo said.

It was unclear whether the results could be applied to all GLP1-class drugs or were specific to semaglutide, Barclays analyst Emily Field said in an interview.

Lange said he expected the company’s application to have Wegovy’s label updated to include the heart benefits to be approved in the U.S. in the first half of next year and in the EU in the second half. Drug regulators can update the information on medicine labels to include new data or reflect new indications for use after initial approval.

U.S. and UK drug regulators approved Eli Lilly’s rival weight-loss treatment on Wednesday, which had previously been approved and marketed as Mounjaro for diabetes.

(Reporting by Patrick WingroveEditing by Caroline Humer, Bill Berkrot and Diane Craft)

tagreuters.com2023binary_LYNXMPEJAA041-VIEWIMAGE

Categories
Technology

OpenAI investors see more startup opportunities despite ChatGPT expansion

(This Nov. 9 story has been corrected to say Avery Klemmer is an investor, not a partner, in paragraph 7)

By Krystal Hu

(Reuters) – OpenAI’s announcement on artificial intelligence “apps” do not spell the death knell for nascent startups building AI products, two OpenAI investors said at a Reuters NEXT conference on Thursday.

Investors are still hunting for new AI products that could help consumers interact better with the technology and address deep tech issues such as brain computer interface, they said.

The owner of the wildly popular ChatGPT chatbot earlier this week unveiled a marketplace that allows users to access personalized AI “apps” for tasks like teaching math or designing stickers.

The news sparked fear among AI startup founders who worry they will not be able to compete with OpenAI, which is trying to build an AI empire with products aimed at both consumers and enterprises.

“There’s so much room for continued innovation in AI. We’re in an intermediary step in a decades-long revolution,” Konstantine Buhler, partner at Sequoia Capital, told the conference. “You can play a very big role in how this is shaped.”

Sequoia invested in OpenAI in 2021, the maker of ChatGPT, in which Microsoft also has a larger stake.

Avery Klemmer, investor at Thrive Capital, which recently increased its investment in OpenAI, also said she sees opportunities for the rise of consumer applications beside ChatGPT.

She expects more innovations based on the existing format of AI chatbots popularized by ChatGPT.

“I think there will be really novel formats and forms of engagement that get invented,” Klemmer said.

Despite recent frenzied investments into the technology by companies and venture capital firms, analysts and investors say development of AI products is still in the early stages.

While it’s still relatively expensive to build applications using large language models, the accelerated pace of research in the space could result in a rapid decline in the cost of AI inference, or using an AI model to make predictions, and inspire new products, Jill Chase, partner at CapitalG, told Reuters NEXT.

“The cost of inference coming down so dramatically may seem like a small thing, but it’s hugely impactful for what types of businesses can be created and what use cases incumbents can empower,” she said.

(Reporting by Krystal Hu in New York; Editing by Sayantani Ghosh and Deepa Babington)

tagreuters.com2023binary_LYNXMPEJA902F-VIEWIMAGE

Categories
Business Crypto Economy Technology US

Silvergate’s deepening crisis jolts crypto stocks

By Manya Saini

(Reuters) – Shares of Silvergate Capital Corp fell 10% in early trading on Monday after the bank suspended its crypto payments network and expressed doubts over the viability of its business.

The crypto-focused bank said late on Friday that it had made a “risk-based decision” to discontinue the Silvergate Exchange Network (SEN) effective immediately.

“The SEN is Silvergate’s main flagship product that previously was the key attraction for depositors to bring funds to the bank,” said analysts at Wedbush.

The discontinuation could signal that Silvergate may consider winding down its operations, they added.

Shares of crypto lending peer Signature Bank also fell roughly 2.5% in morning trade, while crypto exchange Coinbase Global was down nearly 1%. Crypto firm Riot Platforms Inc, and BTC mining machine makers Ebang International and Canaan Inc drop between 1% and 2%.

“The crypto market reacted to the negative news from Silvergate Bank, with both bitcoin and ethereum down about 4.8% for the week,” analysts at brokerage Bernstein said.

Shares of Silvergate hit a record low of $4.86 on Friday, shedding nearly 98% of their value since an all-time high close in November 2021 and wiping out more than $7 billion from the company’s market capitalization.

“We believe a receivership/liquidation scenario is a distinct possibility and arrive at a liquidation value of $5 per share,” Wedbush analysts said. The estimated price marks a roughly 13% downside to the stock’s previous close.

A slew of crypto heavyweights including Coinbase Global have dropped Silvergate as their banking partner.

The firm has been struggling to stay afloat after the collapse of Sam Bankman-Fried’s crypto exchange FTX in November drove investors to pull out $8 billion in deposits from the bank in the last three months of the year.

Silvergate reported a net loss of $1 billion in the fourth quarter.

(Reporting by Manya Saini in Bengaluru; Editing by Anil D’Silva and Devika Syamnath)

Categories
Asia Business Economy Technology US

AI stocks surge as investors bet on growth prospects

(Reuters) -Shares of artificial intelligence-based (AI) product makers zoomed on Friday, as a strong forecast from retail darling C3.ai Inc amplified an ongoing euphoria in the segment driven by the launch of OpenAI’s ChatGPT.

C3.a1 forecast better-than-expected revenue and profit for both the fourth quarter and fiscal year 2023, after its third-quarter results topped Wall Street estimates.

Shares of the AI software provider were up 16% at $24.80, and were one of the top five trending stocks on StockTwits. If the gains hold, the stock is set to notch its strongest one-day gain in a month.

“The company is starting to gain momentum in building significant enterprise opportunities in its pipeline with its suite of innovative enterprise AI solutions,” said Wedbush analyst Daniel Ives.

The firm’s aim to turn cash positive and adjusted profitable by the end of fiscal year 2024 also boosted the stock, but Ives believes the execution of these ambitions is key to regain the Street’s confidence heading into 2023.

Retail investors have flocked to small-cap firms building AI tools as companies such as Google-parent Alphabet Inc and Microsoft Corp have locked horns to make AI the next big growth driver.

Microsoft’s investment in OpenAI’s ChatGPT boosted AI firms’ popularity further. Chatbots like the ChatGPT are software applications that aim to mimic human conversation using artificial intelligence.

Other major AI stocks also surged on Friday with BigBear.ai, conversation intelligence firm SoundHound AI, and Thailand’s security firm Guardforce AI jumping between 5% and 20%.

So far this year, these stocks, including C3.ai, have surged 33.9%-321.6%, as of the previous day’s close.

“AI could become the new gold rush on Wall Street,” said Adam Sarhan, chief executive officer of 50 Park Investments in Florida.

“But it still needs some more time to mature a bit, better price action, and prove that it can generate profits for investors.”

(Reporting by Ankika Biswas in Bengaluru; editing by Uttaresh Venkateshwaran)

tagreuters.com2023binary_LYNXMPEJ220G4-VIEWIMAGE

tagreuters.com2023binary_LYNXMPEJ220G3-VIEWIMAGE

Categories
Business Economy Europe Technology US

EV Maker Polestar’s Q4 Loss Narrows, Won’t Engage in Price Wars

By Marie Mannes

(Reuters) – Electric vehicle (EV) maker Polestar on Thursday posted a smaller quarterly loss, maintained its 2023 production outlook and said it would not engage in price wars while weakening demand has forced some rivals to scale back output.

This year is proving to be a tough one for EV makers, as a Tesla-ignited price war and continued supply chain bottlenecks further strain start-ups hoping to benefit from the shift to EVs.

While some carmakers have followed Tesla’s lead and cut EV prices, Polestar says it has no intention of doing so, taking the same stance as former parent company Volvo Cars.

“We will not engage in a price war…we are aiming to become a very premium sportscar company…,” chief executive Thomas Ingenlath told Reuters. “It’s very clear that this is a completely different aim from where Tesla is going, with 20 million cars per year.”

Demand for electric cars has weakened for U.S. EV startups Rivian and Lucid, with both carmakers forecasting 2023 production well below analyst estimates.

But Polestar reaffirmed the 2023 production outlook it gave in January of 80,000 cars, up from the roughly 51,000 it delivered in 2022.

Ingenlath said he saw supply chain issues that have hampered global auto production easing in 2023, and 2022 has left the carmaker with a strong order book.

“This year will be a little bit more normal,” he said.

The Swedish carmaker, founded by China’s Geely and Volvo Cars, posted a fourth quarter operating loss of $204.7 million, down from $337.3 million a year ago. The company reported a gross profit of $61.9 million versus a loss of $0.2 million in the same quarter in 2021.

The U.S-listed company said it expected its gross profit for 2023 to broadly be in line with the $119.4 million it reported for 2022.

(Reporting by Marie Mannes;Editing by Elaine Hardcastle)

 

Categories
Business Europe Politics Technology Top News US

Lockheed’s HIMARS Plant Gearing Up to Meet Demand After Ukraine Success

By Mike Stone

CAMDEN, Arkansas (Reuters) – Lockheed Martin’s mobile rocket launcher plant in Camden, Arkansas is gearing up to boost production of the HIMARS system after its success on the battlefield in Ukraine drove up demand from other nations, executives said on Monday.

The High Mobility Artillery Rocket System (HIMARS) is now a widely recognized weapon after mobile phone camera footage of the war in Ukraine showed the launchers in action.

“When you have a combat proven system that is out there and in the news – daily – then that’s driving that demand,” said Jennifer McManus, the vice president for operations of Lockheed’s missile business.

Lockheed Martin makes HIMARS and refurbishes an older version in Camden, a small town southwest of Little Rock.

Thanks to some investments made over the last year in the 282,000 square foot building where the ground vehicles are made, Lockheed only needs a few upgrades to meet that increased production rate, Lockheed executives said.

The list includes a paint booth, non-skid coating mixer, tire assembly manipulator arm and an axel installation track, the executives told Reuters.

On an earnings call with investors Lockheed’s CEO said “on HIMARS specifically, we’ve already met with our long lead supply chain to plan for increasing production to 96 of these units a year.” Lockheed started 2022 with a HIMARS launcher production rate of 48, but has since ramped up to 60 year.

The HIMARS launcher had been growing in popularity even before its success in Ukraine.

Poland was cleared in February to purchase 18 HIMARS launchers and 468 launcher loader kits that can be in installed on Polish-made trucks to turn into them into similar launch platforms. Talks for that deal began in 2017, a Lockheed spokesperson told Reuters.

 

(Reporting by Mike Stone in Camden, Arkansas; Editing by Stephen Coates)

 

 

 

Categories
Asia Business Crypto Economy Technology US

Cryptoverse: Bitcoin moves towards Satoshi’s payment dream

By Medha Singh and Lisa Pauline Mattackal

(Reuters) – Satoshi Nakamoto would be proud. Adolescent bitcoin may finally be repaying its creator’s faith.

The 15-year-old cryptocurrency has filled many roles – from source of speculation to hedge against inflation – but has struggled to find a clear identity. Now there are growing signs it’s edging towards its intended purpose: payments.

“The development in terms of building out crypto payments has continued apace, even if it’s gone somewhat unnoticed because of the volatility in the broader market,” said Richard Mico, U.S. CEO of Banxa, a payment-and-compliance infrastructure provider.

The amount of bitcoin stored on the Lightning Network – a payment protocol layered on top of the blockchain – has jumped by two-thirds over the past year to hit an all-time high of 5,580 coin, according to crypto data firm The Block.

Crypto payment specialists have also seen strong volumes.

U.S.-based BitPay said transaction volumes jumped 18% last year versus 2021. CoinsPaid said volumes in the fourth quarter of 2022 rose 32% compared with a year before.

BITCOIN AND BRAZILIAN REAL

So why has crypto failed to fulfill pseudonymous inventor Nakamoto’s dream, spelt out in a famed 2008 white paper titled “Bitcoin: A Peer-to-Peer Electronic Cash System”?

Price volatility, slow processing speeds and persistent regulatory uncertainty are among the factors that have rendered cryptocurrencies unwieldy as a means of payment. Few merchants price good or services in crypto.

Nonetheless, proponents say bitcoin offers lower transaction costs and quicker speeds than traditional cash, especially for cross-border transfers.

Aside from bitcoin, other cryptocurrencies including stablecoins, which are pegged to the value of traditional currencies, have emerged as popular options, particularly for cross-border payments, remittances, plus in emerging markets where the value of local currencies have been hit by inflation.

Stellar, a blockchain that enables cross-border payments, saw the number of trades on its platform increase to 103.4 million last month from 50.6 million in January 2022.

Volumes for trades across exchanges between bitcoin and Turkey’s lira and Brazil’s real increased by 232% and 72%, respectively, CryptoCompare data showed.

CAN YOU HANDLE THE STRESS?

It’s not all smooth sailing for the widespread adoption of crypto for payments; for one thing, there’s the question of whether blockchains are ready to handle the stress of processing thousands of transactions at a time, especially without a simultaneous jump in transaction fees.

Efforts by some of the world’s largest economies, including Japan, China and India, to create their own digital currencies (CBDCs) could also choke crypto payments growth, say some market players. For others, though, growing interest in CBDCs is evidence that blockchain payments tech is here to stay.

Traditional finance firms looking to embrace crypto payments have also shrugged off recent market volatility. One, Visa inking a deal this month with crypto firm WireX to directly issue crypto-enabled debit and prepaid cards.

“Crypto is evolving into a viable alternative for more and more people around the world,” said Mico at Banxa.

 

(Reporting by Lisa Pauline Mattackal and Medha Singh in Bengaluru; Editing by Tom Wilson and Pravin Char)